Merck

Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls
TheStreet.com
Sat, 02/3/18 - 09:07 am
pharma execs
M&A
earnings
drug pricing
Pfizer
Ian Read
Merck
Ken Frazier
Enrique Conterno
Eli Lilly
Merck hands off to Jim Kelly for Super Bowl, World Cancer Day combo campaign
Medical Marketing and Media
Sat, 02/3/18 - 09:04 am
Merck
Super Bowl
World Cancer Day
drug ads
social media
Merck expects a flat tax rate in 2018 as peers see benefit from reform
Fierce Pharma
Fri, 02/2/18 - 11:01 pm
Merck
taxes
tax reform
Merck quarterly profit beats on Keytruda demand
Yahoo/Reuters
Fri, 02/2/18 - 09:41 am
Merck
earnings
Keytruda
Why Merck (MRK) Might Surprise This Earnings Season
Yahoo/Zacks.com
Thu, 02/1/18 - 09:44 am
Merck
earnings
Merck R&D chief Roger Perlmutter offers some heavyweight R&D glam to a little upstart biotech out to cure Duchenne MD
Endpoints
Tue, 01/30/18 - 09:26 am
Merck
R&D
Roger Perlmutter
Duchenne Muscular Dystrophy
Exonics Therapeutics
Merck spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D
Endpoints
Mon, 01/29/18 - 10:30 am
Merck
antibiotics
R&D
Prokaryotics
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
Sat, 01/20/18 - 02:56 pm
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
Merck & Co.’s shares rise over 7% thanks to new positive clinical results from Keytruda
GoinPharma
Wed, 01/17/18 - 09:44 pm
Merck
Keytruda
non-squamous cell non-small cell lung cancer
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Wed, 01/17/18 - 10:05 am
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Merck's Keytruda extends lung cancer survival in combination trial
Yahoo/Reuters
Tue, 01/16/18 - 10:01 am
Merck
Keytruda
lung cancer
clinical trials
Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return
Fierce Pharma
Mon, 01/15/18 - 10:37 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
melanoma
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Fri, 01/12/18 - 06:39 pm
Merck
Eisai
Keytruda
Lenvima
kidney cancer
Drug pricing pressure isn't likely to get worse: Merck CEO
Fierce Pharma
Tue, 01/9/18 - 11:49 pm
drug pricing
Merck
Kenneth Frazier
Pharma CEOs
JPMHC 2018
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
Oncology business to keep leading pharma market in 2018
GoinPharma
Wed, 12/27/17 - 09:39 am
oncology
Merck
Bristol-Myers Squibb
Pfizer
Roche
FDA Pulls Boxed Warnings on Asthma Risks on Some Inhalers
RAPS.org
Thu, 12/21/17 - 10:35 pm
FDA
warnings
asthma
inhalers
ICS/LABA inhalers
GSK
Advair Diskus
AstraZeneca
Symbicort
Merck
Dulera
Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes
Endpoints
Thu, 12/21/17 - 10:07 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
tugliflozin
Merck and ViiV are keeping it real with their TV ads. Which drugmakers will follow?
Fierce Pharma
Wed, 12/20/17 - 11:06 pm
Merck
ViiV
television ads
DTC ads

Pages